Revvity Discloses Scope 3 Emissions for First Time in 2026 Impact Report
Event summary
- Revvity published its 2026 Impact Report, including first-time disclosure of Scope 3 emissions.
- Company reduced Scope 1 and 2 greenhouse gas emissions by 1.3% in 2025 (16% total reduction from 2022 baseline).
- Achieved 49% non-hazardous diversion rate, exceeding annual goal of 40%.
- Launched Revvity Supports Research initiative with $180,000 in grants to 12 academic institutions.
The big picture
Revvity's expanded sustainability reporting aligns with growing investor and regulatory demands for transparency in Scope 3 emissions. The company's focus on ESG initiatives reflects broader industry trends toward responsible business practices, particularly in healthcare technology. With $2.9 billion in 2025 revenue and a global customer base, Revvity's strategic moves could set benchmarks for peers in translational multi-omics and diagnostic technologies.
What we're watching
- Sustainability Commitments
- How Revvity will integrate Scope 3 emissions data into future strategic planning and whether it can maintain its reduction trajectory.
- Workforce Development
- The impact of internal promotions on long-term talent retention and operational efficiency.
- Research Investment
- Whether the Revvity Supports Research initiative will yield measurable advancements in aligned scientific fields.